Is TruScreen Group Limited (TRU.NZ) a Buy, Sell, or Hold?
TruScreen Group Limited
NZE:TRU.NZ
$0.027 NZD
$0.0 (8.0%)
- Volume
- 534.98K
- Average Volume
- 435K
- Market Capitalization
- $14.92M
- P/E Ratio
- -4.29
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.03
- Year Low
- $0.02
- Payout Ratio
- $0.00
- Current Ratio
- $5.24
Industry, Sector & symbol
| Stock Exchange | NZSE |
| CEO | Mr. Martin Dillon |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | TRU.NZ |
| CUSIP | None |
| CIK | None |
| Web | https://truscreen.com |
| Phone | 61 2 8999 3896 |
| Currency | NZD |
| Employees | 6 |
| Country | NZ |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 5.24 |
| Quick Ratio | 4.60 |
| Cash Ratio | 3.55 |
Sales & Book Value
| Annual Sales | $2.11M |
| Price / Sales | 4.96 |
| Cash Flow | 0.00 |
| Price / Cash Flow | -7.10 |
| Price / Book | 3.62 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0049 |
| Trailing P/E Ratio | -4.29 |
| PEG Ratio | -0.16 |
| P/E Growth | -0.16 |
| Net Income | $-2.05M |
| Net Margin | -90.78% |
| Pretax Margin | -118.77% |
| Return on Equity | -123.15% |
| Return on Assets | -67.70% |
Financials Score
| AltmanZ Score | -1.61 |
| Piotroski Score | 3.00 |
| Working Capital | 3.26M |
| Total Assets | 4.03M |
| Ebit | -2.75M |
| Market Cap | 14.92M |
| Total Liabilities | 798.45K |
Poll Results
About TruScreen Group Limited (NZE:TRU.NZ) Stock
Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand. ...
Frequently Asked Questions
-
What is the current TruScreen Group Limited (TRU.NZ) stock price?
-
TruScreen Group Limited(NZE:TRU.NZ) stock price is $0.027 in the last trading session. During the trading session, TRU.NZ stock reached the peak price of $0.029318 while $0.015 was the lowest point it dropped to. The percentage change in TRU.NZ stock occurred in the recent session was 8.0% while the dollar amount for the price change in TRU.NZ stock was $0.0.
-
TRU.NZ's industry and sector of operation?
-
The NZE listed TRU.NZ is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of TRU.NZ?
-
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | Chief Financial Officer & Company Secretary
Mr. Edmond Capcelea | Chief Technology Officer
Dr. . Phunc | Head of Cancer Department
Dr. . Thuy | Head of High Service Gynaecology Examination
Mr. Martin Dillon | Chief Executive Officer -
How many employees does TRU.NZ have?
-
Number of TRU.NZ employees currently stands at 6. TRU.NZ operates from Equitable House, Auckland, None 1010, NZ.
-
Link for TRU.NZ official website?
-
Official Website of TRU.NZ is: https://truscreen.com
-
How do I contact TRU.NZ?
-
TRU.NZ could be contacted at phone #61 2 8999 3896 and can also be accessed through its website. TRU.NZ operates from Equitable House, Auckland, None 1010, NZ.
-
How many shares of TRU.NZ are traded daily?
-
The average number of TRU.NZ shares traded daily for last 3 months was 435K.
-
What is the market cap of TRU.NZ currently?
-
The market value of TRU.NZ currently stands at $14.92M with its latest stock price at $0.027